{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:23:31Z","timestamp":1777584211823,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"DOI":"10.1186\/s12941-024-00772-6","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T19:20:23Z","timestamp":1737141623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative In vitro antibacterial activity of nemonoxacin and other fluoroquinolones in correlation with resistant mechanisms in contemporary methicillin-resistant Staphylococcus aureus blood isolates in Taiwan"],"prefix":"10.1186","volume":"24","author":[{"given":"Pao -Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Wang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Jen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng Len","family":"Sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Taiwan Staphylococcus aureus Consortium (TSAC)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"772_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"RC Antimicrobial","year":"2022","unstructured":"Antimicrobial RC. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"key":"772_CR2","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1093\/jac\/dkac237","volume":"77","author":"DTP Buis","year":"2022","unstructured":"Buis DTP, Prins JM, Betica-Radic L, de Boer MGJ, Ekkelenkamp M, Kofteridis D, Peiffer-Smadja N, Schouten J, Spernovasilis N, Tattevin P, Ten Oever J, Sigaloff KCE. Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia: results from a survey in five European countries. J Antimicrob Chemother. 2022;77:2827\u201334. https:\/\/doi.org\/10.1093\/jac\/dkac237.","journal-title":"J Antimicrob Chemother"},{"key":"772_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad666","author":"D de Kretser","year":"2023","unstructured":"de Kretser D, Mora J, Bloomfield M, Campbell A, Cheng MP, Guy S, Hensgens M, Kalimuddin S, Lee TC, Legg A, Mahar RK, Marks M, Marsh J, McGlothlin A, Morpeth SC, Sud A, Ten Oever J, Yahav D, Tong SY, Davis JS, Walls G, Goodman AL, Bonten M, Staphylococcus aureus Network Adaptive Platform Study Group m. Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) trial early oral switch protocol. Clin Infect Dis. 2023. https:\/\/doi.org\/10.1093\/cid\/ciad666.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"772_CR4","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.1086\/321846","volume":"33","author":"LR Peterson","year":"2001","unstructured":"Peterson LR. Quinolone molecular structure-activity relationships: what we have learned about improving antimicrobial activity. Clin Infect Dis. 2001;33(Suppl 3):S180\u20136. https:\/\/doi.org\/10.1086\/321846.","journal-title":"Clin Infect Dis"},{"key":"772_CR5","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1128\/AAC.00078-09","volume":"53","author":"HJ Adam","year":"2009","unstructured":"Adam HJ, Laing NM, King CR, Lulashnyk B, Hoban DJ, Zhanel GG. In vitro activity of nemonoxacin, a novel nonfluorinated quinolone, against 2,440 clinical isolates. Antimicrob Agents Chemother. 2009;53:4915\u201320. https:\/\/doi.org\/10.1128\/AAC.00078-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"772_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1089\/mdr.2019.0048","volume":"26","author":"JJ Yang","year":"2020","unstructured":"Yang JJ, Cheng A, Tai HM, Chang LW, Hsu MC, Sheng WH. Selected mutations by nemonoxacin and fluoroquinolone exposure among relevant gram-positive bacterial strains in Taiwan. Microb Drug Resist. 2020;26:110\u20137. https:\/\/doi.org\/10.1089\/mdr.2019.0048.","journal-title":"Microb Drug Resist"},{"key":"772_CR7","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/jac\/dkp370","volume":"64","author":"YH Chen","year":"2009","unstructured":"Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan. J Antimicrob Chemother. 2009;64:1226\u20139. https:\/\/doi.org\/10.1093\/jac\/dkp370.","journal-title":"J Antimicrob Chemother"},{"key":"772_CR8","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1128\/AAC.01197-09","volume":"54","author":"TL Lauderdale","year":"2010","unstructured":"Lauderdale TL, Shiau YR, Lai JF, Chen HC, King CH. Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates. Antimicrob Agents Chemother. 2010;54:1338\u201342. https:\/\/doi.org\/10.1128\/AAC.01197-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"772_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060816","author":"KT Peng","year":"2019","unstructured":"Peng KT, Huang TY, Chiang YC, Hsu YY, Chuang FY, Lee CW, Chang PJ. Comparison of Methicillin-Resistant Staphylococcus aureus Isolates from Cellulitis and from Osteomyelitis in a Taiwan Hospital, 2016\u20132018. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8060816.","journal-title":"J Clin Med"},{"key":"772_CR10","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1080\/22221751.2021.1981158","volume":"10","author":"PY Chen","year":"2021","unstructured":"Chen PY, Chuang YC, Wang JT, Sheng WH, Chen YC, Chang SC. Sequence type 8 as an emerging clone of methicillin-resistant Staphylococcus aureus causing bloodstream infections in Taiwan. Emerg Microbes Infect. 2021;10:1908\u201318. https:\/\/doi.org\/10.1080\/22221751.2021.1981158.","journal-title":"Emerg Microbes Infect"},{"key":"772_CR11","doi-asserted-by":"publisher","first-page":"106534","DOI":"10.1016\/j.ijantimicag.2022.106534","volume":"59","author":"YC Huang","year":"2022","unstructured":"Huang YC, Chen CJ. USA300 (sequence type 8) has become a major clone of methicillin-resistant Staphylococcus aureus in northern Taiwan. Int J Antimicrob Agents. 2022;59:106534. https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106534.","journal-title":"Int J Antimicrob Agents"},{"key":"772_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2105-10-152","volume":"10","author":"AP Francisco","year":"2009","unstructured":"Francisco AP, Bugalho M, Ramirez M, Carrico JA. Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach. BMC Bioinformatics. 2009;10:152. https:\/\/doi.org\/10.1186\/1471-2105-10-152.","journal-title":"BMC Bioinformatics"},{"key":"772_CR13","volume-title":"Performance standards for antimicrobial susceptibility testing. CLSI supplement M100","author":"CLSI","year":"2023","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100. 33rd ed. Malvern: Clinical and Laboratory Standards Institute; 2023.","edition":"33"},{"key":"772_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jgar.2020.10.017","volume":"23","author":"SS Jean","year":"2020","unstructured":"Jean SS, Chang LW, Hsueh PR. Tentative clinical breakpoints and epidemiological cut-off values of nemonoxacin for Streptococcus pneumoniae and Staphylococcus aureus isolates associated with community-acquired pneumonia. J Glob Antimicrob Resist. 2020;23:388\u201393. https:\/\/doi.org\/10.1016\/j.jgar.2020.10.017.","journal-title":"J Glob Antimicrob Resist"},{"key":"772_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","volume":"22","author":"LS Redgrave","year":"2014","unstructured":"Redgrave LS, Sutton SB, Webber MA, Piddock LJ. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol. 2014;22:438\u201345. https:\/\/doi.org\/10.1016\/j.tim.2014.04.007.","journal-title":"Trends Microbiol"},{"key":"772_CR16","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126:1763\u20138. https:\/\/doi.org\/10.1213\/ANE.0000000000002864.","journal-title":"Anesth Analg"},{"key":"772_CR17","doi-asserted-by":"publisher","first-page":"e9489","DOI":"10.1371\/journal.pone.0009489","volume":"5","author":"JL Wang","year":"2010","unstructured":"Wang JL, Wang JT, Chen SY, Chen YC, Chang SC. Distribution of Staphylococcal cassette chromosome mec types and correlation with comorbidity and infection type in patients with MRSA bacteremia. PLoS ONE. 2010;5:e9489. https:\/\/doi.org\/10.1371\/journal.pone.0009489.","journal-title":"PLoS ONE"},{"key":"772_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jhin.2018.02.014","volume":"100","author":"YC Huang","year":"2018","unstructured":"Huang YC, Chen CJ, Kuo CC, Lu MC. Emergence, transmission and phylogeny of meticillin-resistant Staphylococcus aureus sequence type 8 (USA300) in Taiwan. J Hosp Infect. 2018;100:355\u20138. https:\/\/doi.org\/10.1016\/j.jhin.2018.02.014.","journal-title":"J Hosp Infect"},{"key":"772_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2147\/DDDT.S63581","volume":"8","author":"X Qin","year":"2014","unstructured":"Qin X, Huang H. Review of nemonoxacin with special focus on clinical development. Drug Des Devel Ther. 2014;8:765\u201374. https:\/\/doi.org\/10.2147\/DDDT.S63581.","journal-title":"Drug Des Devel Ther"},{"key":"772_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jgar.2019.05.026","volume":"19","author":"TLR de Oliveira","year":"2019","unstructured":"de Oliveira TLR, Cavalcante FS, Chamon RC, Ferreira RBR, Dos Santos KRN. Genetic mutations in the quinolone resistance-determining region are related to changes in the epidemiological profile of methicillin-resistant Staphylococcus aureus isolates. J Glob Antimicrob Resist. 2019;19:236\u201340. https:\/\/doi.org\/10.1016\/j.jgar.2019.05.026.","journal-title":"J Glob Antimicrob Resist"},{"key":"772_CR21","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jmii.2021.08.013","volume":"55","author":"CY Lee","year":"2022","unstructured":"Lee CY, Fang YP, Wu TH, Chang YF, Sung CH. Sequence types 8, 59, and 45 methicillin resistant Staphylococcus aureus as the predominant strains causing skin and soft tissue infections in Taiwan\u2019s prisons and jails. J Microbiol Immunol Infect. 2022;55:1239\u201345. https:\/\/doi.org\/10.1016\/j.jmii.2021.08.013.","journal-title":"J Microbiol Immunol Infect"},{"key":"772_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12061070","author":"CC Kao","year":"2023","unstructured":"Kao CC, Lai CH, Wong MY, Huang TY, Tseng YH, Lu CH, Lin CC, Huang YK. Insight into the clonal lineage and antimicrobial resistance of Staphylococcus aureus from vascular access infections before and during the COVID-19 pandemic. Antibiotics. 2023. https:\/\/doi.org\/10.3390\/antibiotics12061070.","journal-title":"Antibiotics"},{"key":"772_CR23","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1093\/cid\/ciz787","volume":"70","author":"A Iregui","year":"2020","unstructured":"Iregui A, Khan Z, Malik S, Landman D, Quale J. Emergence of delafloxacin-resistant Staphylococcus aureus in Brooklyn, New York. Clin Infect Dis. 2020;70:1758\u201360. https:\/\/doi.org\/10.1093\/cid\/ciz787.","journal-title":"Clin Infect Dis"},{"key":"772_CR24","doi-asserted-by":"publisher","first-page":"106795","DOI":"10.1016\/j.ijantimicag.2023.106795","volume":"61","author":"JMO de la Rosa","year":"2023","unstructured":"de la Rosa JMO, Fernandez MA, Rodriguez-Villodres A, Casimiro-Soriguer CS, Cisneros JM, Lepe JA. High-level delafloxacin resistance through the combination of two different mechanisms in Staphylococcus aureus. Int J Antimicrob Agents. 2023;61:106795. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106795.","journal-title":"Int J Antimicrob Agents"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-024-00772-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-024-00772-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-024-00772-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T19:20:25Z","timestamp":1737141625000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-024-00772-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1186\/s12941-024-00772-6","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"7 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board in each participating hospital (National Taiwan University Hospital, 202102038RIPA; China Medical University Hospital, CMUH110-REC3-103; Chi Mei Medical Center, 11010-002; Kaohsiung Medical University Hospital, KMUHIRB-E(I)-20210168; Kaohsiung Veteran General Hospital, KSVGH21-CT11-06).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}